Atlas Trials

Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia

Clinical trial NCT02210962 · UNKNOWN

Trial details

NCT number
NCT02210962
Sponsor
Medical University of Lodz
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-09-01
Primary completion
2015-02-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.